2, 3-dihydro-1H-indene compounds and their use to treat cancer

Details for Australian Patent Application No. 2010258437 (hide)

Owner AstraZeneca AB

Inventors Aquila, Brian; Hennessy, Edward; Hird, Alexander; Oza, Vibha; Saeh, Jamel Carlos; Sha, Li

Agent Davies Collison Cave

Pub. Number AU-A-2010258437

PCT Pub. Number WO2010/142994

Priority 61/186,594 12.06.09 US

Filing date 10 June 2010

Wipo publication date 16 December 2010

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/142994 Priority application(s): WO2010/142994

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258438-Lighting apparatus

2010258429-Waste screening apparatus and methods